Your browser doesn't support javascript.
loading
Measles vaccination in Africa: by how much could routine coverage be improved?
Edmunds, W J; Gay, N J; Henao Restrepo, A M; Olivé, J M; Bele, O.
Afiliação
  • Edmunds WJ; PHLS Communicable Disease Surveillance Centre, NW9 5EQ, London, UK. jedmunds@phls.org.uk
Vaccine ; 20(1-2): 16-8, 2001 Oct 12.
Article em En | MEDLINE | ID: mdl-11567740
ABSTRACT
Assuming that the level of Bacille Calmette Guerin (BCG) coverage gives a measure of access to immunisation services, it is possible to derive what fraction of infants are not immunised against measles due to under-utilisation of existing services (rather than unavailability of services). According to the most recent official statistics, the overall coverage for measles vaccine is 53% in Africa (10% lower than for BCG). This difference amounts to 3 million African children who will not be vaccinated against measles this year even though they probably have access to immunisation services.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacinação Tipo de estudo: Evaluation_studies Limite: Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Reino Unido
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacinação Tipo de estudo: Evaluation_studies Limite: Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2001 Tipo de documento: Article País de afiliação: Reino Unido